BioPen “paints” ion biosensors onto cells
Being able to monitor signaling events on a cellular level is important for understanding many biological processes. In…
Fluicell positioned to accelerate growth
In this edition of the Fluicell CEO Newsletter, Victoire Viannay talks about the advances that Fluicell has made…
19
Nov
2021
“We have a great challenge, but also the opportunity to make a difference”
This year marks the 100th anniversary of the first successful insulin injection. The injection was given to the…
14
Nov
2021
Biopixlar highlighted in Advanced Materials article
Being able to fabricate functional organs in a laboratory as an alternative to transplanted organs is one of…
10
Nov
2021
Biopixlar user experience: an important stepping stone for the field
Dr. Luiz E. Bertassoni of Oregon Health and Science University, who has been using the Biopixlar platform since…
13
Oct
2021
Fluicell CEO Newsletter 06, 2021
In the sixth issue of the Fluicell CEO Newsletter for 2021, Victoire Viannay covers Fluicell’s advances in regenerative…
29
Sep
2021
Fluicell makes progress in early development of advanced therapy medicinal products for diabetes based on Biopixlar
Today, Fluicell announces that the company has made important progress in the early development work regarding a medicinal…
16
Sep
2021
Fluicell at Erik Penser Bank Life Science Day
Fluicell’s CEO Victoire Viannay will present the company, what our current focus is and our plans for the…
14
Sep
2021
Pressure differences influence cell division
Cytokinesis, or cell division, is one of the most fundamental process in biology. The division of one cell…
25
Aug
2021